ID: ALA2414978

Max Phase: Preclinical

Molecular Formula: C12H9N3

Molecular Weight: 195.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2c3c([nH]c2c1)-c1n[nH]cc1C3

Standard InChI:  InChI=1S/C12H9N3/c1-2-4-10-8(3-1)9-5-7-6-13-15-11(7)12(9)14-10/h1-4,6,14H,5H2,(H,13,15)

Standard InChI Key:  NDMWWUUFGUNZRU-UHFFFAOYSA-N

Associated Targets(Human)

MAPK10 Tchem Mitogen-activated protein kinase 10/Receptor-interacting serine/threonine-protein kinase 1 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.22Molecular Weight (Monoisotopic): 195.0796AlogP: 2.46#Rotatable Bonds: 0
Polar Surface Area: 44.47Molecular Species: ACIDHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.84CX Basic pKa: 2.31CX LogP: 2.45CX LogD: 0.88
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.44Np Likeness Score: -0.50

References

1. Wu Z, Li Y, Cai Y, Yuan J, Yuan C..  (2013)  A novel necroptosis inhibitor-necrostatin-21 and its SAR study.,  23  (17): [PMID:23886688] [10.1016/j.bmcl.2013.06.073]

Source